Join our host, MS Australia CEO, Rohan Greenland and guests, Dr Julia Morahan, MS Australia’s Head of Research, and Dr Therese Burke, an MS Certified Nurse and MS Australia’s Clinical Platform Coordinator.
In this, MS Australia’s inaugural ‘The Raw Nerve’ Podcast, Rohan and guests discuss some of the big issues showcased at the world’s largest MS Research Conference - ECTRIMS 2022, the 27th Annual Conference of the European / committee for Treatment and Research in Multiple Sclerosis.
Rohan speaks with Therese about a workshop highlighting the critical importance of MS Nurses in ensuring the best possible outcomes for people living with MS. (01:28)
Also announced at ECTRIMS – the results from PREVANZ – an MS Australia clinical trial examining whether vitamin D supplements prevented MS development in people at high risk. As Rohan and Julia explain; the findings raise many interesting questions. (06:23)
Other ECTRIM highlights discussed this week; paediatric onset MS (11:19), the importance of early detection of MS (12:13), an introduction to Adaptive Clinical Trials – a new way of looking at clinical trials (20:05), and finally, a look at behavioural risk factors for MS (21:54)
Landmark report on MS Nurse Care in Australia released
World first clinical trial finds Vitamin D supplements do not prevent the development of MS
Episode TranscriptViews expressed on the Raw Nerve Podcast, including any discussions or reference to medications or treatments by podcast guests, do not necessarily represent the views of MS Australia and should not be seen as either an endorsement or rejection of a treatment.
MS Australia does not recommend any specific treatment for people living with MS. Decisions about any treatments, taking into consideration the potential benefits and side effects for each individual’s circumstances, should be made in careful consultation with the person’s neurologist.